Description
Average to Epic is an integrated guide for helping men and women transform their lives through endurance sports. It could be riding a bike 100 miles, running a marathon, or completing long-course triathlons, this book provides the resources, practical tips, planning, and motivation for the average person to take on epic athletic challenges. It covers endurance road biking, endurance mountain biking, long distance running, and triathlons. Many middle-aged people want to drastically improve their fitness and overall wellness. Taking that first step is often difficult. Motivation is hard because of time commitments and lack of information, guidance, and experience in endurance sports. Average to Epic provides motivation by demystifying the world of endurance sports and helping the reader take the first steps in getting into one of these sports and training for an epic event. It helps the aspiring triathlete through the murky waters of their first triathlon as they work toward a half-Iron (70.3) or Ironman™; takes the non-runner or 5k weekend warrior through the mysteries of running form on their way to completing their first marathon; demystifies the world of cycling to encourage the reader to ride 100 miles on a bike. In doing so, this book helps the reader achieve a broader and more important goal: lifelong fitness.
About the Author
Don Rose is Director of UNC’s KickStart Venture Services, an entrepreneurial technology commercialization program in the Office of Commercialization and Economic Development. In addition, he is an Adjunct Professor at UNC’s Kenan-Flagler Business School. Prior to that, he held senior leadership roles at a number of life science startups: Metabolon (metabolomics, RTP), Deerac Fluidics (nanoliter dispensing, Dublin), and DataCentric Automation (high-throughput crystallography, Nashville). Before that, he was a general partner with Catalysta Partners (now Hatteras Venture Partners), a seed stage venture fund specializing in information technology and biotechnology start-ups. During this time, Don was co-founder and CEO of Phase Bioscience, a biomaterials start-up, spun out of Duke University. Prior to Catalysta, he was co-founder and VP of Research and Development for Cartesian Technologies, a leader in instrumentation for DNA microarrays and nanoliter dispensing. Prior to Cartesian, Dr. Rose was a research scientist at Glaxo Wellcome (now GSK) where he developed and promoted a number of technologies in bioanalytical chemistry, combinatorial chemistry and high-throughput screening. Prior to GW, Dr. Rose developed various aspects of capillary electrophoreses instrumentation at Hewlett-Packard Laboratories. Dr. Rose received his Ph.D. in Analytical Chemistry and BS in Nutrition from the University of North Carolina. He has published eight papers, two book chapters, and holds six US patents.
